🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate the efficacy and safety of c...
Status
Recruiting
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Start Date
2024-03-11
Trial ID
NCT06363006
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Status
Unknown
Location
Beijing Ditan Hospital, Capital Medical University
Start Date
2019-09-01
Trial ID
NCT04127396
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
Combination treatment with antiangiogenic agents and anti-programmed cell d...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2020-12-23
Trial ID
NCT04639284
Treatments Being Tested
This multicenter, prospective, randomized, controlled, open-label, two-arm ...
Status
Recruiting
Location
Jinan, Shandong 0531
Start Date
2025-07-21
Trial ID
NCT06841172
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - NAHOA Prescott Valley /ID# 254313
Start Date
2023-09-21
Trial ID
NCT05822752
Treatments Being Tested
China is a high-risk area of Hepatocellular Carcinoma (HCC). Although Chine...
Status
Unknown
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-11-01
Trial ID
NCT05420922
Treatments Being Tested
Following the results of the randomized clinical trial IMbrave150, the comb...
Status
Completed
Location
Fondazione Policlinico Agostino Gemelli IRCCS
Start Date
2023-07-27
Trial ID
NCT07193316
Treatments Being Tested
This is a Phase III, open-label, multicenter, randomized, two-arm study des...
Status
Active Not Recruiting
Location
Medizinische Universität Innsbruck
Start Date
2021-04-26
Trial ID
NCT04770896
Treatments Being Tested